Estonia - Potential Years of Life Lost from Pancreas Malignant Neoplasms
Since 2014, Estonia Potential Years of Life Lost from Pancreas Malignant Neoplasms was up 2.4% year on year. In 2019, the country was number 3 comparing other countries in Potential Years of Life Lost from Pancreas Malignant Neoplasms with 139.5 Years Per Hundred Thousand Men Aged 0-69. Estonia is overtaken by Latvia, which was number 2 at 148.9 Years Per Hundred Thousand Men Aged 0-69 and is followed by Lithuania at 133.9 Years Per Hundred Thousand Men Aged 0-69. Hungary ranked the highest with 167.1 Years Per Hundred Thousand Men Aged 0-69 in 2019, a growth of 0.2% versus 2018. Costa Rica recorded the best 5 years average growth at +8.5% per year, while Iceland recorded the worst performance at -20.9% per year.
Loading...
| Date | Years Per Hundred Thousand Men Aged 0-69 |
|---|---|
| 2019 | 139.50 |
| 2018 | 156.70 |
| 2017 | 102.10 |
| 2016 | 95.90 |
| 2015 | 119.10 |
How does Estonia rank in Potential Years of Life Lost from Pancreas Malignant Neoplasms?
| # | 39 Countries | Years Per Hundred Thousand Men Aged 0-69 | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Hungary
|
167.10 | 2019 | +0.2 % | +0.7 % | View data |
| 2 |
#2
Latvia
|
148.90 | 2019 | -0.8 % | -2.0 % | View data |
| 3 |
#3
Estonia
|
139.50 | 2019 | -11.0 % | +2.4 % | View data |
| 4 |
#4
Lithuania
|
133.90 | 2019 | -4.6 % | -2.3 % | View data |
| 5 |
#5
Czech Republic
|
121.00 | 2019 | -1.2 % | -0.8 % | View data |